KELLY MICKULIK: Open Payments
NPI 1386643880 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,207 in 151 payments from 27 companies in 2025. Trend: 2023 $3,589 · 2024 $3,112 · 2025 $3,207
Food & beverage: $3,040Education: $167
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $501 |
| ABBVIE INC. | 28 | $447 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $293 |
| UCB, Inc. | 15 | $285 |
| Novartis Pharmaceuticals Corporation | 8 | $181 |
| Galderma Laboratories, L.P. | 15 | $180 |
| GENZYME CORPORATION | 5 | $158 |
| LEO Pharma Inc. | 6 | $155 |
| Lilly USA, LLC | 8 | $124 |
| Amgen Inc. | 5 | $109 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, NEMLUVIO, ILUMYA, ADBRY, OTEZLA, TALTZ.
Industry payments across PA — which companies pay providers there.
